🇯🇵 Japan • Results & Revisions Review - Wishful Thinking
4TH DOWN AND A FEW MORE TO GO - The latest quarterly results are now, with the exception of three large insurance companies are currently in the...
434 Views
Update on Astellas (4503) As It Gets Orphan Drug Status for Gilteritinib
News that gilteritinib has received orphan drug status for acute myeloid leukaemia (AML) would be rather more exciting for Astellas (4503 JP) but...
305 Views
Nikkei 225 Replacement of Toshiba - A Closer Look
About a week and a half ago, just after the TSE announced the demotion of Toshiba Corp (6502 JP) from the TSE's first section effective August 1st,...
617 Views
The Week That Was in NorthAsia@Smartkarma: Toshiba, Peptidream, and Missiles
It's been a full week for coverage of North Asia on Smartkarma. 30-odd insights on Japan and a dozen on Korea.ToshibaThe big theme of the week, and...
462 Views
Medrx - Japan Biotech Microcap in Potential Big Licensing Deal
Although the Japanese drug industry suffers from a lack of scale, where it is good is in applying manufacturing techniques to develop not just...
550 Views